Bruni L, Albero G, Rowley J, et al. Global and regional estimates of genital human papillomavirus prevalence among men: a systematic review and meta-analysis. Lancet Glob Health. 2023;11(9):e1345–62.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Markowitz LE, Dunne EF, Saraiya M, et al. Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2014;63(RR-05):1–30.

PubMed  Google Scholar 

Tota JE, Chevarie-Davis M, Richardson LA, Devries M, Franco EL. Epidemiology and burden of HPV infection and related diseases: implications for prevention strategies. Prev Med. 2011;53(Suppl 1):S12-21.

Article  PubMed  Google Scholar 

Alemany L, Cubilla A, Halec G, et al. Role of human papillomavirus in penile carcinomas worldwide. Eur Urol. 2016;69(5):953–61.

Article  PubMed  Google Scholar 

Sun J, Xiong J, Zhen Y, Chen ZL, Zhang H. P53 and PCNA is positively correlated with HPV infection in laryngeal epitheliopapillomatous lesions in patiets with different ethnic backgrounds in Xinjiang. Asian Pac J Cancer Prev. 2012;13(11):5439–44.

Article  PubMed  Google Scholar 

Weiss D, Heinkele T, Rudack C. Reliable detection of human papillomavirus in recurrent laryngeal papillomatosis and associated carcinoma of archival tissue. J Med Virol. 2015;87(5):860–70.

Article  CAS  PubMed  Google Scholar 

Lam EWH, Chan MMH, Wai CKC, et al. The role of human papillomavirus in laryngeal cancer in Southern China. J Med Virol. 2018;90(6):1150–9.

Article  CAS  PubMed  Google Scholar 

Elbasha EH, Dasbach EJ, Insinga RP. Model for assessing human papillomavirus vaccination strategies. Emerg Infect Dis. 2007;13(1):28–41.

Article  PubMed  PubMed Central  Google Scholar 

Elbasha EH, Dasbach EJ. Impact of vaccinating boys and men against HPV in the United States. Vaccine. 2010;28(42):6858–67.

Article  PubMed  Google Scholar 

Burger EA, Campos NG, Sy S, Regan C, Kim JJ. Health and economic benefits of single-dose HPV vaccination in a Gavi-eligible country. Vaccine. 2018;36(32 Pt A):4823–9.

Article  PubMed  PubMed Central  Google Scholar 

Kim JJ. Could 1 dose be less efficacious than 2 doses but still be a great public health intervention? HPV World. https://www.hpvworld.com/media/29/media_section/0/5/1605/kim.pdf. Accessed 28 Aug 2023.

Drolet M, Laprise JF, Martin D, et al. Optimal human papillomavirus vaccination strategies to prevent cervical cancer in low-income and middle-income countries in the context of limited resources: a mathematical modelling analysis. Lancet Infect Dis. 2021;21(11):1598–610.

Article  PubMed  PubMed Central  Google Scholar 

Daniels V, Prabhu VS, Palmer C, et al. Public health impact and cost-effectiveness of catch-up 9-valent HPV vaccination of individuals through age 45 years in the United States. Hum Vaccin Immunother. 2021;17(7):1943–51.

Article  PubMed  PubMed Central  Google Scholar 

Daniels V, Saxena K, Patterson-Lomba O, et al. Modeling the health and economic implications of adopting a 1-dose 9-valent human papillomavirus vaccination regimen in a high-income country setting: an analysis in the United Kingdom. Vaccine. 2022;40(14):2173–83.

Article  PubMed  Google Scholar 

Rihan FA. Delay differential equations and applications to biology. Singapore: Springer; 2021.

Book  Google Scholar 

Wang WV, Kothari S, Skufca J, et al. Real-world impact and effectiveness of the quadrivalent HPV vaccine: an updated systematic literature review. Expert Rev Vaccines. 2022;21(12):1799–817.

Article  CAS  PubMed  Google Scholar 

Goodman E, Reuschenbach M, Kaminski A, Ronnebaum S. Human papillomavirus vaccine impact and effectiveness in six high-risk populations: a systematic literature review. Vaccines (Basel). 2022;10(9):1543.

Article  PubMed  Google Scholar 

Cumpston M, Li T, Page MJ, et al. Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Database Syst Rev. 2019;10:142.

Google Scholar 

Moher D, Liberati A, Tetzlaff J, Altman D, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol. 2009;62(10):1006–12.

Article  PubMed  Google Scholar 

PubMed. https://pubmed.ncbi.nlm.nih.gov/about/. Accessed 28 Aug 2023.

R Core Team. R: a language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2021.

Google Scholar 

Tatti S, Stockfleth E, Beutner KR, et al. Polyphenon E: a new treatment for external anogenital warts. Br J Dermatol. 2010;162(1):176–84.

Article  CAS  PubMed  Google Scholar 

Anic GM, Lee JH, Stockwell H, et al. Incidence and human papillomavirus (HPV) type distribution of genital warts in a multinational cohort of men: the HPV in men study. J Infect Dis. 2011;204(12):1886–92.

Article  PubMed  PubMed Central  Google Scholar 

Garland SM, Steben M, Sings HL, et al. Natural history of genital warts: analysis of the placebo arm of 2 randomized phase III trials of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine. J Infect Dis. 2009;199(6):805–14.

Article  PubMed  Google Scholar 

Pitman R, Fisman D, Zaric GS, et al. Dynamic transmission modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-5. Value in Health. 2012;15(6):828–34.

Article  PubMed  PubMed Central  Google Scholar 

Ng SS, Hutubessy R, Chaiyakunapruk N. Systematic review of cost-effectiveness studies of human papillomavirus (HPV) vaccination: 9-Valent vaccine, gender-neutral and multiple age cohort vaccination. Vaccine. 2018;36(19):2529–44.

Article  PubMed  Google Scholar 

Cantor SB, Atkinson EN, Cardenas-Turanzas M, Benedet JL, Follen M, MacAulay C. Natural history of cervical intraepithelial neoplasia: a meta-analysis. Acta Cytol. 2005;49(4):405–15.

Article  PubMed  Google Scholar 

Melnikow J, Nuovo J, Willan AR, Chan BK, Howell LP. Natural history of cervical squamous intraepithelial lesions: a meta-analysis. Obstet Gynecol. 1998;92(4 Pt 2):727–35.

CAS  PubMed  Google Scholar 

Ostör AG. Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol. 1993;12(2):186–92.

Article  PubMed  Google Scholar 

Syrjänen KJ. Spontaneous evolution of intraepithelial lesions according to the grade and type of the implicated human papillomavirus (HPV). Eur J Obstet Gynecol Reprod Biol. 1996;65(1):45–53.

Article  PubMed  Google Scholar 

Insinga RP, Dasbach EJ, Elbasha EH. Epidemiologic natural history and clinical management of human papillomavirus (HPV) disease: a critical and systematic review of the literature in the development of an HPV dynamic transmission model. BMC Infect Dis. 2009;9:119.

Article  PubMed  PubMed Central  Google Scholar 

Daly C, Dias S, Welton N, Anwer S, Ades A. NICE Guidelines Technical Support Unit. Meta-analysis: guideline methodology document 1. 2021. https://www.bristol.ac.uk/media-library/sites/social-community-medicine/documents/mpes/gmd-1-meta-analysis-jan2021.pdf. Accessed 28 Aug 2023.

Rosales R, López-Contreras M, Rosales C, et al. Regression of human papillomavirus intraepithelial lesions is induced by MVA E2 therapeutic vaccine. Hum Gene Ther. 2014;25(12):1035–49.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Harper DM, Nieminen P, Donders G, et al. The efficacy and safety of Tipapkinogen Sovacivec therapeutic HPV vaccine in cervical intraepithelial neoplasia grades 2 and 3: Randomized controlled phase II trial with 2.5 years of follow-up. Gynecol Oncol. 2019;153(3):521–9.

Article  PubMed  Google Scholar 

de Cremoux P, de la Rochefordière A, Savignoni A, et al. Different outcome of invasive cervical cancer associated with high-risk versus intermediate-risk HPV genotype. Int J Cancer. 2009;124(4):778–82.

Article  PubMed  Google Scholar 

Lei J, Ploner A, Lagheden C, et al. High-risk human papillomavirus status and prognosis in invasive cervical cancer: a nationwide cohort study. PLoS Med. 2018;15(10):e1002666.

Article  PubMed  PubMed Central  Google Scholar 

Haupt RM, Wheeler CM, Brown DR, et al. Impact of an HPV6/11/16/18 L1 virus-like particle vaccine on progression to cervical intraepithelial neoplasia in seropositive women with HPV16/18 infection. Int J Cancer. 2011;129(11):2632–42.

Article  CAS  PubMed  Google Scholar 

Insinga RP, Perez G, Wheeler CM, et al. Incident cervical HPV infections in young women: transition probabilities for CIN and infection clearance. Cancer Epidemiol Biomark Prev. 2011;20(2):287–96.

Article  Google Scholar 

Matsumoto K, Oki A, Furuta R, et al. Predicting the progression of cervical precursor lesions by human papillomavirus genotyping: a prospective cohort study. Int J Cancer. 2011;128(12):2898–910.

Article  CAS  PubMed  Google Scholar 

Grimm C, Polterauer S, Natter C, et al. Treatment of cervical intraepithelial neoplasia with topical imiquimod. Int J Gynecol Cancer. 2011;21(Suppl 3):46.

Google Scholar 

Jaisamrarn U, Castellsagué X, Garland SM, et al. Natural history of progression of HPV infection to cervical lesion or clearance: analysis of the control arm of the large, randomised PATRICIA study. PLoS ONE. 2013;8(11):e79260.

Article  PubMed  PubMed Central  Google Scholar 

Okonogi N, Kobayashi D, Suga T, et al. Human papillomavirus genotype affects metastatic rate following radiotherapy in patients with uterine cervical cancer. Oncol Lett. 2018;15(1):459–66.

PubMed